Comparison · NSE · data 2026-11-02
Indo US Bio-Tech Ltd. vs TBI Corn Limited
In plain words
Size: Indo US Bio-Tech Ltd. is about 1.2 times the market value of TBI Corn Limited.
Valuation (P/E): Indo US Bio-Tech Ltd. 31.5 vs TBI Corn Limited 6.9.
Profit growth over 3 years: TBI Corn Limited 44% a year vs Indo US Bio-Tech Ltd. 21.9% a year.
Debt to equity: TBI Corn Limited 0.59 vs Indo US Bio-Tech Ltd. 0.4.
Differences in the numbers, not a recommendation of either stock.
Side by side
| INDOUS | TBI | |
|---|---|---|
| Price | ₹68.1 | ₹69.25 |
| Market cap | ₹148 cr | ₹124 cr |
| P/E | 31.5 | 6.9 |
| P/B | 1.5 | 1.1 |
| ROE | 15.3% | 16.8% |
| ROCE | 18.8% | 27.7% |
| Debt / equity | 0.4 | 0.59 |
| Operating margin | 7.9% | 10.6% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 21.4% | 38.1% |
| Profit growth, 3 years (yearly) | 21.9% | 44.0% |
| 1-year return | -50.8% | -21.3% |
| Revenue, last 12 months | ₹97 cr | ₹304 cr |
| Net profit, last 12 months | ₹4 cr | ₹18 cr |
| Latest quarter | Sept 2026 | — |
| Quarter net profit | ₹-4 cr | — |
| Quarter profit vs a year earlier | -206.4% | — |
| Promoter holding | 68.29% | — |
| Health check | Average (4/10) | Strong (7.5/10) |
Common questions
Which has a higher P/E, Indo US Bio-Tech Ltd. or TBI Corn Limited?
Indo US Bio-Tech Ltd. trades at the higher P/E (31.5 against 6.9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
TBI Corn Limited (16.8% against 15.3%).
Which carries more debt?
TBI Corn Limited has the higher debt-to-equity ratio (0.59 against 0.4).